Veru Inc. (VERU)
Largest Insider Buys in Sector
VERU Stock Price History Chart
VERU Stock Performance
About Veru Inc.
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N. agencies, nonprofit organizations, and commercial partners. The company's development drug candidates include Enobosarm, an oral selective androgen receptor agonist that is in phase III clinical trial for the treatment of AR+ ER+ HER2- metastatic breast cancer; Sabizabulin, which is phase IIb clinical trial for the treatment of AR+ ER+ HER2- metastatic breast cancer; Enobosarm + abemaciclib combination therapy, which is in phase III clinical trial for the treatment of AR+ ER+ HER2- metastatic breast cancer; and Sabizabulin + enobosarm combination therapy, an oral targeted cytoskeleton disruptor plus selective androgen receptor agonist, which is in phase II clinical trial for the treatment of metastatic triple negative breast cancer. Its drug candidates also comprise Sabizabulin, which is in Phase II clinical trial for the treatment of metastatic castration and androgen receptor targeting agent resistant prostate cancer; VERU-100, a GnRH antagonist peptide injection, which is in Phase II clinical trial for the treatment of advanced hormone sensitive prostate cancer; Zuclomiphene Citrate, which is in Phase II clinical trial for treating hot flashes; and Sabizabulin, which is in phase III clinical trial for the treatment of SARS-CoV-2 in subjects at high risk for acute respiratory distress syndrome. In addition, the company is advancing a new drug formulation for the treatment of men with lower urinary tract symptoms from an enlarged prostate. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Insider Activity of Veru Inc.
Over the last 12 months, insiders at Veru Inc. have bought $21,696 and sold $334,454 worth of Veru Inc. stock.
On average, over the past 5 years, insiders at Veru Inc. have bought $67,932 and sold $1.85M worth of stock each year.
Highest buying activity among insiders over the last 12 months: FISCH HARRY (Chief Corporate Officer) — $14,999. BARNETTE K GARY (Chief Scientific Officer) — $6,697.
The last purchase of 4,000 shares for transaction amount of $5,000 was made by FISCH HARRY (Chief Corporate Officer) on 2024‑05‑24.
List of Insider Buy and Sell Transactions, Veru Inc.
| 2024-05-24 | Sale | STEINER MITCHELL SHUSTER | President and CEO | 63,379 0.042% | $1.23 | $78,102 | -26.02% | |
| 2024-05-24 | FISCH HARRY | Chief Corporate Officer | 4,000 0.0027% | $1.25 | $5,000 | -26.02% | ||
| 2024-05-24 | BARNETTE K GARY | Chief Scientific Officer | 5,000 0.0036% | $1.34 | $6,697 | -26.02% | ||
| 2024-05-23 | Sale | STEINER MITCHELL SHUSTER | President and CEO | 300 0.0002% | $1.35 | $405 | -27.70% | |
| 2024-05-22 | Sale | STEINER MITCHELL SHUSTER | President and CEO | 6,504 0.0045% | $1.39 | $9,018 | -33.35% | |
| 2024-05-17 | Sale | STEINER MITCHELL SHUSTER | President and CEO | 28,066 0.0177% | $1.32 | $36,988 | -28.52% | |
| 2024-05-16 | Sale | STEINER MITCHELL SHUSTER | President and CEO | 59,788 0.0403% | $1.41 | $84,128 | -31.04% | |
| 2024-05-15 | Sale | STEINER MITCHELL SHUSTER | President and CEO | 84,021 0.0585% | $1.50 | $125,813 | -34.24% | |
| 2024-05-15 | FISCH HARRY | Chief Corporate Officer | 6,711 0.0046% | $1.49 | $9,999 | -34.24% | ||
| 2022-08-15 | Sale | Eisenberger Mario | 100,000 0.1275% | $20.04 | $2M | -77.26% | ||
| 2021-08-17 | Lu Lucy | director | 4,800 0.006% | $6.78 | $32,542 | +23.97% | ||
| 2021-06-16 | Sale | FISCH HARRY | 100,000 0.1237% | $8.35 | $835,300 | -8.26% | ||
| 2021-03-10 | Hyun Grace | director | 3,500 0.0048% | $14.09 | $49,315 | -40.69% | ||
| 2021-02-12 | Sale | STEINER MITCHELL SHUSTER | President and CEO | 20,000 0.0267% | $20.88 | $417,688 | -59.84% | |
| 2020-12-16 | Sale | STEINER MITCHELL SHUSTER | President and CEO | 250,000 0.3447% | $9.69 | $2.42M | -12.86% | |
| 2020-12-16 | Sale | BARNETTE K GARY | Chief Scientific Officer | 100,000 0.1515% | $10.65 | $1.06M | -12.86% | |
| 2020-08-26 | FISCH HARRY | 5,000 0.0075% | $2.76 | $13,800 | +195.80% | |||
| 2020-08-24 | Greco Michele | CAO and CFO | 5,000 0.0075% | $2.65 | $13,233 | +205.47% | ||
| 2020-02-21 | FISCH HARRY | 1,000 0.0015% | $4.47 | $4,470 | -29.30% | |||
| 2020-02-20 | FISCH HARRY | 1,000 0.0015% | $4.51 | $4,510 | -29.80% |
Insider Historical Profitability
| FISCH HARRY | 774736 0.5219% | $0.80 | 34 | 1 | +29.19% | |
| STEINER MITCHELL SHUSTER | President and CEO | 6942709 0.1298% | $0.80 | 12 | 39 | +4.18% |
| BARNETTE K GARY | Chief Scientific Officer | 5000 0% | $0.80 | 3 | 1 | +34.34% |
| DEARHOLT STEPHEN M | director | 1978899 1.3519% | $0.80 | 6 | 22 | <0.0001% |
| PARRISH O B | director | 844849 0.5772% | $0.80 | 9 | 5 | +7.59% |
| WENNINGER RICHARD E | director | 821778 0.5614% | $0.80 | 0 | 55 | |
| BETHUNE DAVID R | director | 435982 0.2978% | $0.80 | 9 | 0 | +6.15% |
| KERBER JAMES R | director | 421766 0.2881% | $0.80 | 1 | 7 | |
| WALTON MICHAEL R | director | 395056 0.2699% | $0.80 | 3 | 6 | +6.68% |
| PEERSCHKE ELGAR | director | 145520 0.0994% | $0.80 | 4 | 0 | +18.42% |
| LOVE ANDREW S JR | director | 114926 0.0785% | $0.80 | 10 | 0 | <0.0001% |
| GARGIULO WILLIAM R JR | director | 102500 0.07% | $0.80 | 4 | 2 | <0.0001% |
| Greco Michele | CAO and CFO | 96178 0.0657% | $0.80 | 3 | 0 | +101.86% |
| HAINES DANIEL | Chief Financial Officer | 83931 0.0573% | $0.80 | 6 | 0 | +24.55% |
| King Karen Louise | President and CEO | 69500 0.0475% | $0.80 | 2 | 0 | <0.0001% |
| Felch Donna | director | 64382 0.044% | $0.80 | 2 | 7 | +6.29% |
| LEEPER MARY ANN | director | 48000 0.0328% | $0.80 | 1 | 17 | <0.0001% |
| Socorro Jesus | director | 32500 0.0222% | $0.80 | 5 | 0 | +9.61% |
| Frank Mary Margaret | director | 30962 0.0212% | $0.80 | 0 | 1 | |
| ZIC ROBERT | Vice President - Finance | 27250 0.0186% | $0.80 | 0 | 22 | |
| Hyun Grace | director | 14790 0.0101% | $0.80 | 1 | 0 | <0.0001% |
| Lu Lucy | director | 9800 0.0067% | $0.80 | 2 | 0 | +27.52% |
| POPE MICHAEL | VP and General Manager | 250 0.0002% | $0.80 | 2 | 25 | +31.71% |
| Eisenberger Mario | 0 0% | $0.80 | 0 | 1 |
Institutional Investor Ownership
| Adage Capital Partners Gp L L C | $7.72M | 7.53 | 11.02M | -19.68% | -$1.89M | 0.01 | |
| Perceptive Advisors | $3.91M | 3.82 | 5.58M | 0% | +$0 | <0.01 | |
| The Vanguard Group | $3.3M | 3.22 | 4.72M | +0.17% | +$5,623.20 | <0.0001 | |
| Octagon Capital Advisors LP | $2.66M | 2.6 | 3.8M | 0% | +$0 | 0.35 | |
| Morgan Stanley | $1.91M | 1.87 | 2.73M | +0.06% | +$1,176.17 | <0.0001 | |
| Altium Capital Management Lp | $1.48M | 1.44 | 2.11M | +5.59% | +$78,222.88 | 0.69 | |
| Laurion Capital Management LP | $1.19M | 1.16 | 1.7M | 0% | +$0 | 0.03 | |
| J. Goldman & Company | $966,454.00 | 0.94 | 1.38M | -14.12% | -$158,957.05 | 0.04 | |
| BlackRock | $916,504.00 | 0.89 | 1.31M | +11.56% | +$94,974.90 | <0.0001 | |
| Geode Capital Management | $796,027.00 | 0.78 | 1.14M | +71.67% | +$332,316.45 | <0.0001 | |
| Millennium Management LLC | $792,319.00 | 0.77 | 1.13M | +188.17% | +$517,368.12 | <0.01 | |
| Susquehanna International Group | $674,298.00 | 0.66 | 963,145 | +282.78% | +$498,140.19 | <0.01 | |
| Ikarian Capital LLC | $662,563.00 | 0.65 | 946,382 | New | +$662,563.00 | 0.19 | |
| Alpine Global Management, LLC | $497,071.00 | 0.49 | 710,000 | +20.95% | +$86,111.60 | 0.03 | |
| Envestnet Asset Management Inc | $256,795.00 | 0.25 | 366,798 | New | +$256,795.00 | <0.0001 | |
| Blair William Co Il | $231,033.00 | 0.23 | 330,000 | 0% | +$0 | <0.01 | |
| Ubs Oconnor Llc | $209,485.00 | 0.2 | 299,221 | -57.25% | -$280,585.88 | 0.02 | |
| Northern Trust | $184,738.00 | 0.18 | 263,874 | +78.85% | +$81,446.05 | <0.0001 | |
| Boothbay Fund Management LLC | $184,873.00 | 0.18 | 264,067 | New | +$184,873.00 | 0.01 | |
| State Street | $151,964.00 | 0.15 | 217,061 | 0% | +$0 | <0.0001 | |
| 180 Wealth Advisors LLC | $119,542.00 | 0.12 | 170,750 | New | +$119,542.00 | 0.02 | |
| Level Four Advisory Services Llc | $89,627.00 | 0.09 | 124,482 | 0% | +$0 | <0.01 | |
| Bank of America | $79,270.00 | 0.08 | 113,242 | -0.07% | -$55.30 | <0.0001 | |
| Rsm Us Wealth Management Llc | $64,350.00 | 0.06 | 91,916 | New | +$64,350.00 | <0.01 | |
| LINSCO PRIVATE LEDGER CORP | $63,670.00 | 0.06 | 90,944 | -2.53% | -$1,652.24 | <0.0001 | |
| Xtx Topco Ltd | $61,977.00 | 0.06 | 88,526 | New | +$61,977.00 | <0.01 | |
| Hrt Financial Llc | $54,000.00 | 0.05 | 77,519 | -9.33% | -$5,555.41 | <0.0001 | |
| Hightower Advisors | $47,000.00 | 0.05 | 70,472 | +10.71% | +$4,547.81 | <0.0001 | |
| Kestra Private Wealth Services | $44,597.00 | 0.04 | 63,701 | 0% | +$0 | <0.01 | |
| T. Rowe Price | $45,000.00 | 0.04 | 63,300 | 0% | +$0 | <0.0001 | |
| Mendel Capital Management Llc | $41,889.00 | 0.04 | 59,833 | 0% | +$0 | 0.03 | |
| American Money Management Llc | $41,672.00 | 0.04 | 59,523 | New | +$41,672.00 | 0.01 | |
| Segment Wealth Management LLC | $42,006.00 | 0.04 | 60,000 | 0% | +$0 | <0.01 | |
| Integrated Wealth Concepts Llc | $35,636.00 | 0.04 | 50,900 | +366.97% | +$28,004.72 | <0.01 | |
| Cetera Advisors LLC | $33,143.00 | 0.03 | 47,341 | New | +$33,143.00 | <0.0001 | |
| Point72 Asia Singapore Pte Ltd | $26,827.00 | 0.03 | 38,319 | New | +$26,827.00 | <0.01 | |
| Cubist Systematic Strategies | $25,769.00 | 0.03 | 36,808 | New | +$25,769.00 | <0.0001 | |
| Cetera Investment Advisers | $23,626.00 | 0.02 | 33,747 | New | +$23,626.00 | <0.0001 | |
| Gladstone Institutional Advisory Llc | $22,403.00 | 0.02 | 32,000 | New | +$22,403.00 | <0.01 | |
| SeaCrest Investment Management, LLC | $20,303.00 | 0.02 | 29,000 | New | +$20,303.00 | <0.01 | |
| Advisor Group Holdings Inc | $19,935.00 | 0.02 | 28,481 | +86.03% | +$9,218.91 | <0.0001 | |
| Cambridge Investment Research Advisors Inc | $19,000.00 | 0.02 | 26,480 | New | +$19,000.00 | <0.0001 | |
| BNY Mellon | $17,088.00 | 0.02 | 24,408 | -3.78% | -$671.39 | <0.0001 | |
| Group One Trading | $16,055.00 | 0.02 | 22,932 | -52.01% | -$17,399.22 | <0.0001 | |
| Aveo Capital Partners, LLC | $34,638.00 | 0.02 | 21,250 | -15% | -$6,112.59 | 0.01 | |
| SG Americas Securities, LLC | $15,000.00 | 0.02 | 21,544 | +29.57% | +$3,423.46 | <0.0001 | |
| State Board of Administration of Florida | $25,764.00 | 0.02 | 22,210 | New | +$25,764.00 | <0.0001 | |
| Weaver Consulting Group | $15,604.00 | 0.02 | 22,288 | New | +$15,604.00 | 0.01 | |
| Paradigm Financial Partners Llc | $14,002.00 | 0.01 | 20,000 | 0% | +$0 | <0.01 | |
| Virtu Financial Llc | $14,000.00 | 0.01 | 20,232 | -79.63% | -$54,737.15 | <0.01 |